Please login to the form below

Verona Pharma

This page shows the latest Verona Pharma news and features for those working in and with pharma, biotech and healthcare.

Vernalis accepts £33m takeover offer from Ligand Pharma

Vernalis accepts £33m takeover offer from Ligand Pharma. After mulling over several takeover offers, UK biotech Vernalis has been won over by an overture from California’s Ligand Pharma that values ... Clinical-stage pipeline projects include Verona

Latest news

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO

Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO. He takes over from the UK biotech company's co-founder Michael Walker. ... Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO.
The power of small

Putting his money where his mouth is, Trevor joined Verona Pharma, a small, start-up biotech, as non-executive director of the board in September 2006. ... The Author. Michael Walker, PhD is chief executive officer and co-founder of Verona Pharma.
Malcolm's Market Eye: 6 to 12 October 2007

Verona Pharma may have secured go ahead for chronic respiratory drug. ... Verona Pharma, the life sciences company, is focusing on therapeutic drugs with which to treat asthma, hay- fever and other chronic respiratory ailments.

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

Dr Desiree Luthman joins Verona Pharma

Dr Desiree Luthman joins Verona Pharma. She takes up its vice president position. ... Jan-Anders Karlsson, chief executive officer of Verona Pharma, said: “We welcome Desiree to our growing pharma team.
Verona Pharma strengthens senior management team

Verona Pharma has appointed Richard Hennings in a role that will see him oversee the firm’s marketing access strategy and increase its commercial focus. ... Jan-Anders Karlsson, CEO of Verona Pharma, said: “We are delighted to welcome Richard to the
Mereo BioPharma’s Richard Bungay to step down

He has previously held the chief financial title at Glide Pharmaceutical Technologies, Chroma Therapeutics and Verona Pharma, remaining as a non-executive board director at both Glide and Chroma.
Vikas Sinha joins Verona as non-executive director

UK drug development company Verona Pharma has appointed Vikas Sinha as a non-executive director. ... Dr David Ebsworth, chairman of Verona Pharma, said: “ Vikas' impressive financial background, including his US expertise, makes him a very welcome
Verona names David Ebsworth as non-executive chairman

Verona Pharma has appointed Dr David Ebsworth as its non-executive chairman of the board of directors. ... David' significant expertise in the pharma industry strongly supports Verona Pharma's focus on high value commercial opportunities and future growth

More from appointments
Approximately 4 fully matching, plus 2 partially matching documents found.

Featured jobs

Healthcare Communications Account Directors x 2: Salary TBC

Principal Health Economist - North-West: Negotiable

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Client Services Director – Medical Education Agency – North West...: Salary TBC

Medical/ Scientific Director: Salary TBC

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Account Director: Excellent benefits

Associate Medical Director: Excellent PTO, bonus and 401k package

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Senior Account Director development role to Business Director, H...: Excellent package

Account Manager / Account Director: Competative

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Account Manager- Central Oxford and Abingdon: Negotiable

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Account Director: £48, 000 - £60, 000

Consultant Health Economics - London / Oxford: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...